Literature DB >> 9774345

Chromatin interaction mechanism of transcriptional control in vivo.

J Gribnau1, E de Boer, T Trimborn, M Wijgerde, E Milot, F Grosveld, P Fraser.   

Abstract

We have used a kinetic analysis to distinguish possible mechanisms of activation of transcription of the different genes in the human beta globin locus. Based on in situ studies at the single-cell level we have previously suggested a dynamic mechanism of single genes alternately interacting with the locus control region (LCR) to activate transcription. However, those steady-state experiments did not allow a direct measurement of the dynamics of the mechanism and the presence of loci with in situ primary transcript signals from two beta-like genes in cis has left open the possibility that multiple genes in the locus could initiate transcription simultaneously. Kinetic assays involving removal of a block to transcription elongation in conjunction with RNA FISH show that multiple beta gene primary transcript signals in cis represent a transition between alternating transcriptional periods of single genes, supporting a dynamic interaction mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774345      PMCID: PMC1170928          DOI: 10.1093/emboj/17.20.6020

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Transcription of the hypersensitive site HS2 enhancer in erythroid cells.

Authors:  D Tuan; S Kong; K Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

2.  Autonomous developmental control of human embryonic globin gene switching in transgenic mice.

Authors:  N Raich; T Enver; B Nakamoto; B Josephson; T Papayannopoulou; G Stamatoyannopoulos
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

3.  Control of formation of two distinct classes of RNA polymerase II elongation complexes.

Authors:  N F Marshall; D H Price
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

4.  A transcriptional enhancer whose function imposes a requirement that proteins track along DNA.

Authors:  D R Herendeen; G A Kassavetis; E P Geiduschek
Journal:  Science       Date:  1992-05-29       Impact factor: 47.728

5.  Importance of globin gene order for correct developmental expression.

Authors:  O Hanscombe; D Whyatt; P Fraser; N Yannoutsos; D Greaves; N Dillon; F Grosveld
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

6.  Individual stage selector element mutations lead to reciprocal changes in beta- vs. epsilon-globin gene transcription: genetic confirmation of promoter competition during globin gene switching.

Authors:  K P Foley; J D Engel
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

7.  Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice.

Authors:  T Enver; N Raich; A J Ebens; T Papayannopoulou; F Costantini; G Stamatoyannopoulos
Journal:  Nature       Date:  1990-03-22       Impact factor: 49.962

8.  Human gamma- to beta-globin gene switching in transgenic mice.

Authors:  R R Behringer; T M Ryan; R D Palmiter; R L Brinster; T M Townes
Journal:  Genes Dev       Date:  1990-03       Impact factor: 11.361

9.  Human gamma-globin genes silenced independently of other genes in the beta-globin locus.

Authors:  N Dillon; F Grosveld
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

10.  Developmental regulation of a complete 70-kb human beta-globin locus in transgenic mice.

Authors:  J Strouboulis; N Dillon; F Grosveld
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

View more
  42 in total

1.  Variegated expression of the endogenous immunoglobulin heavy-chain gene in the absence of the intronic locus control region.

Authors:  D Ronai; M Berru; M J Shulman
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes.

Authors:  M Bulger; J H van Doorninck; N Saitoh; A Telling; C Farrell; M A Bender; G Felsenfeld; R Axel; M Groudine; J H von Doorninck
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  The role of the -50 region of the human gamma-globin gene in switching.

Authors:  M S Ristaldi; D Drabek; J Gribnau; D Poddie; N Yannoutsous; A Cao; F Grosveld; A M Imam
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

4.  Inefficient processing impairs release of RNA from the site of transcription.

Authors:  N Custódio; M Carmo-Fonseca; F Geraghty; H S Pereira; F Grosveld; M Antoniou
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

Review 5.  Locus control regions.

Authors:  Qiliang Li; Kenneth R Peterson; Xiangdong Fang; George Stamatoyannopoulos
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

Review 6.  The regulatory network controlling beta-globin gene switching.

Authors:  W Shen; D P Liu; C C Liang
Journal:  Mol Biol Rep       Date:  2001       Impact factor: 2.316

Review 7.  Regulation of human fetal hemoglobin: new players, new complexities.

Authors:  Arthur Bank
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

Review 8.  Gene expression within a dynamic nuclear landscape.

Authors:  Yaron Shav-Tal; Xavier Darzacq; Robert H Singer
Journal:  EMBO J       Date:  2006-07-13       Impact factor: 11.598

9.  Beta-globin intergenic transcription and histone acetylation dependent on an enhancer.

Authors:  Aeri Kim; Hui Zhao; Ina Ifrim; Ann Dean
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

10.  AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.

Authors:  Davide F Robbiani; Anne Bothmer; Elsa Callen; Bernardo Reina-San-Martin; Yair Dorsett; Simone Difilippantonio; Daniel J Bolland; Hua Tang Chen; Anne E Corcoran; André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.